Preparation, characterization, and in vitro degradation of bioresorbable and bioactive composites based on Bioglass-filled polylactide foams.

Highly porous poly(D,L-lactide)/Bioglass composites scaffolds were prepared by thermally induced phase separation process of polymer solutions and subsequent solvent sublimation. A series of composite foams with different polymer/Bioglass weight ratios was prepared to study the influence of Bioglass content on the foam characteristics such as porous structure, density, and pore volume. The pore volume was decreased from 9.5 to 5.7 cm(3)/g when the Bioglass content was increased up to 40 wt %, but the overall pore morphology was not affected very much by changing the polymer/glass composition ratio. The composites foams were then incubated in phosphate-buffered saline at 37 degrees C to study the in vitro degradation of the polymer and to detect hydroxyapatite (HA) formation as an indication of their bioactivity. The addition of Bioglass to polymer foams increased the water absorption and weight loss as compared with pure polymer foams. However, the polymer molecular weight, determined by size exclusion chromatography, was found to decrease more rapidly and to a larger extent in absence of Bioglass. This delayed degradation rate in the composite foams was probably caused by the dissolution of alkaline ions from the Bioglass, resulting in a buffering effect of the incubation medium. After incubation for 7 days, HA was detected by X-ray diffractometry and Raman spectroscopy and confirmed by environmental scanning electron microscopy and energy-dispersive X-ray analysis. The porous composites developed here are promising materials for bone regeneration applications because the formation of HA on the surface of the pore walls should provide good environment for the adhesion and proliferation of osteoblasts and osteoprogenitor cells.

[1]  Larry L. Hench,et al.  Bonding mechanisms at the interface of ceramic prosthetic materials , 1971 .

[2]  L. Francis,et al.  Porous polymer/bioactive glass composites for soft-to-hard tissue interfaces. , 2002, Journal of biomedical materials research.

[3]  C. Laurencin,et al.  Porous Polymer-Ceramic Systems for Tissue Engineering Support the Formation of Mineralized Bone Matrix , 1995 .

[4]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[5]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[6]  V. Goldberg,et al.  Bone graft options: fact and fancy. , 1994, Orthopedics.

[7]  C. V. van Blitterswijk,et al.  Examination of efferent lymph nodes after 2 years of transcortical implantation of poly(L-lactide) containing plugs: a case report. , 1993, Journal of biomedical materials research.

[8]  C T Laurencin,et al.  Three-dimensional degradable porous polymer-ceramic matrices for use in bone repair. , 1996, Journal of biomaterials science. Polymer edition.

[9]  S. Blacher,et al.  Preparation of macroporous biodegradable poly(L-lactide-co-epsilon-caprolactone) foams and characterization by mercury intrusion porosimetry, image analysis, and impedance spectroscopy. , 2003, Journal of biomedical materials research. Part A.

[10]  J. Hao,et al.  Preparation and mechanical properties of nanocomposites of poly(D,L-lactide) with Ca-deficient hydroxyapatite nanocrystals. , 2001, Biomaterials.

[11]  A R Boccaccini,et al.  Development and in vitro characterisation of novel bioresorbable and bioactive composite materials based on polylactide foams and Bioglass for tissue engineering applications. , 2002, Biomaterials.

[12]  J. Tanaka,et al.  Preparation and mechanical properties of calcium phosphate/copoly-L-lactide composites , 1997, Journal of materials science. Materials in medicine.

[13]  S. Blacher,et al.  Characterization of porous polylactide foams by image analysis and impedance spectroscopy , 2000 .

[14]  Larry L. Hench,et al.  Biomedical materials for new millennium: perspective on the future , 2001 .

[15]  C. Blitterswijk,et al.  Surface modification of hydroxyapatite to introduce interfacial bonding with polyactiveTM 70/30 in a biodegradable composite , 1996 .

[16]  Véronique Maquet,et al.  Image analysis, impedance spectroscopy and mercury porosimetry characterisation of freeze-drying porous materials , 2001 .

[17]  G. Ciapetti,et al.  Cytotoxic effect of bone cements in HL-60 cells: distinction between apoptosis and necrosis. , 2000, Journal of biomedical materials research.

[18]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[19]  E. Wintermantel,et al.  Degradation of poly(D,L)lactide implants with or without addition of calciumphosphates in vivo. , 2001, Biomaterials.

[20]  Jukka Seppälä,et al.  In vitro evaluation of poly(ε-caprolactone-co-DL-lactide)/bioactive glass composites , 2002 .

[21]  Robert Langer,et al.  Preparation and characterization of poly(l-lactic acid) foams , 1994 .

[22]  J. Tanaka,et al.  Preparation of porous composite implant materials by in situ polymerization of porous apatite containing ε-caprolactone or methyl methacrylate , 2001 .

[23]  C T Laurencin,et al.  Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. , 2001, Biomaterials.

[24]  C T Laurencin,et al.  Tissue engineered bone-regeneration using degradable polymers: the formation of mineralized matrices. , 1996, Bone.

[25]  P. Ma,et al.  Porous poly(L-lactic acid)/apatite composites created by biomimetic process. , 1999, Journal of biomedical materials research.

[26]  K. Ruffieux Degradables Osteosynthesesystem aus Polylactid für die maxillofaciale Chirurgie , 1997 .

[27]  L. Hench Bioactive Ceramics: Theory and Clinical Applications , 1994 .

[28]  Y. Shikinami,et al.  Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly L-lactide (PLLA). Part II: practical properties of miniscrews and miniplates. , 2001, Biomaterials.

[29]  P. Ducheyne,et al.  New bioactive, degradable composite microspheres as tissue engineering substrates. , 2000, Journal of biomedical materials research.

[30]  C. Klein,et al.  Evaluation of hydroxylapatite/poly(l-lactide) composites: physico-chemical properties , 1993 .

[31]  A R Boccaccini,et al.  Bioresorbable and bioactive composite materials based on polylactide foams filled with and coated by Bioglass® particles for tissue engineering applications , 2003, Journal of materials science. Materials in medicine.

[32]  O. Böstman,et al.  Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. , 1990, The Journal of bone and joint surgery. British volume.

[33]  W C de Bruijn,et al.  Late degradation tissue response to poly(L-lactide) bone plates and screws. , 1995, Biomaterials.

[34]  P. Ma,et al.  Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. , 1999, Journal of biomedical materials research.

[35]  M. Bonfiglio,et al.  Immunological responses to bone. , 1972 .

[36]  P. Ma,et al.  Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. , 2001, Journal of biomedical materials research.

[37]  Christian Grandfils,et al.  Biodegradable and macroporous polylactide implants for cell transplantation: 1. Preparation of macroporous polylactide supports by solid-liquid phase separation , 1996 .

[38]  N. Baldini,et al.  In vitro testing of the potential for orthopedic bone cements to cause apoptosis of osteoblast-like cells. , 2002, Biomaterials.

[39]  M. Textor,et al.  Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. , 2001, Journal of biomedical materials research.